Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 09:00 am Sale | 13G | IO BIOTECH INC IOBT | Avoro Capital Advisors LLC | 0 0% | -2,055,883 (Position Closed) | View |
| 2024-02-13 9:34 pm Sale | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 7,557,393 11.1% | -658,809 (-8.02%) | View |
| 2024-02-13 7:38 pm Sale | 13G | IO BIOTECH INC IOBT | BANK OF AMERICA CORP BAC | 1,844,185 2.8% | -10,000 (-0.54%) | View |
| 2024-02-13 4:29 pm Sale | 13G | IO BIOTECH INC IOBT | Stonepine Capital Management LLC | 3,641,345 5.4% | -309,271 (-7.83%) | View |
| 2024-02-13 4:06 pm Sale | 13G | IO BIOTECH INC IOBT | HBM Healthcare Investments (Cayman) Ltd. | 3,944,492 6% | -1,578,947 (-28.59%) | View |
| 2023-12-18 5:14 pm Purchase | 13G | IO BIOTECH INC IOBT | Samsara BioCapital L.P. | 3,640,015 5.5% | 3,640,015 (New Position) | View |
| 2023-09-07 10:36 am Purchase | 13G | IO BIOTECH INC IOBT | Kurma Partners | 12,253,230 17.18% | 12,253,230 (New Position) | View |
| 2023-08-16 4:15 pm Purchase | 13G | IO BIOTECH INC IOBT | Stonepine Capital Management LLC | 3,950,616 5.8% | 3,950,616 (New Position) | View |
| 2023-08-15 3:15 pm Purchase | 13G | IO BIOTECH INC IOBT | HBM Healthcare Investments (Cayman) Ltd. | 5,523,439 8.19% | 1,524,008 (+38.11%) | View |
| 2023-08-14 3:45 pm Purchase | 13G | IO BIOTECH INC IOBT | HBM Healthcare Investments (Cayman) Ltd. | 3,999,431 6.1% | 1,578,947 (+65.23%) | View |
| 2023-08-14 3:45 pm Purchase | 13D | IO BIOTECH INC IOBT | Lundbeckfond Invest A/S | 21,851,920 29.6% | 15,802,468 (+261.22%) | View |
| 2023-08-11 4:40 pm Purchase | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 8,216,202 12% | 4,938,270 (+150.65%) | View |
| 2023-02-14 4:45 pm Sale | 13G | IO BIOTECH INC IOBT | RA CAPITAL MANAGEMENT L.P. | 1,127,260 3.9% | -730,495 (-39.32%) | View |
| 2023-02-14 4:06 pm Sale | 13G | IO BIOTECH INC IOBT | PFM Health Sciences LP | 507,640 1.8% | -1,002,496 (-66.38%) | View |
| 2023-02-14 08:11 am Purchase | 13G | IO BIOTECH INC IOBT | BANK OF AMERICA CORP BAC | 1,854,185 6.4% | 1,854,185 (New Position) | View |
| 2022-09-30 4:51 pm Unchanged | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 3,277,932 11.4% | 0 (Unchanged) | View |
| 2022-05-26 11:57 am Unchanged | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 3,277,932 11.3% | 0 (Unchanged) | View |
| 2022-04-25 4:48 pm Purchase | 13G | IO BIOTECH INC IOBT | PFM Health Sciences LP | 1,510,136 5.2% | 1,510,136 (New Position) | View |
| 2022-02-11 4:02 pm Purchase | 13G | IO BIOTECH INC IOBT | HBM Healthcare Investments (Cayman) Ltd. | 2,420,484 8.4% | 2,420,484 (New Position) | View |
| 2022-02-11 10:05 am Purchase | 13G | IO BIOTECH INC IOBT | Avoro Capital Advisors LLC | 2,055,883 7.1% | 2,055,883 (New Position) | View |